140 related articles for article (PubMed ID: 30802217)
1. Vulnerability of gastric and small intestinal mucosa to ulcerogenic action of indomethacin in C57/BL6/J mice and transient receptor potential channel vanilloid type 1 knockout mice.
Yarushkina NI; Sudalina MN; Punin YM; Filaretova LP
J Physiol Pharmacol; 2018 Dec; 69(6):. PubMed ID: 30802217
[TBL] [Abstract][Full Text] [Related]
2. [Experimental study of the impact of a single use of indometacine on the morphological structure of the mucous coat of the stomach and small intestine].
Vymiatina ZK; Ivanova LA; Krylova SG
Eksp Klin Gastroenterol; 2006; (3):32-6, 70. PubMed ID: 17203840
[TBL] [Abstract][Full Text] [Related]
3. The influence of dopamine agonists and antagonists on indomethacin lesions in stomach and small intestine in rats.
Sikirić P; Rotkvić I; Mise S; Krizanac S; Gjuris V; Jukić J; Suchanek E; Petek M; Udovicić I; Kalogjera L
Eur J Pharmacol; 1988 Dec; 158(1-2):61-7. PubMed ID: 2906010
[TBL] [Abstract][Full Text] [Related]
4. Gastro-protective action of lafutidine mediated by capsaicin-sensitive afferent neurons without interaction with TRPV1 and involvement of endogenous prostaglandins.
Fukushima K; Aoi Y; Kato S; Takeuchi K
World J Gastroenterol; 2006 May; 12(19):3031-7. PubMed ID: 16718783
[TBL] [Abstract][Full Text] [Related]
5. Analysis of pathogenic elements involved in gastric lesions induced by non-steroidal anti-inflammatory drugs in rats.
Takeuchi K; Kato S; Nishiwaki H; Hirata T
J Gastroenterol Hepatol; 1997 May; 12(5):360-7. PubMed ID: 9195381
[TBL] [Abstract][Full Text] [Related]
6. Development of intestinal, but not gastric damage caused by a low dose of indomethacin in the presence of rofecoxib.
Yokota A; Taniguchi M; Tanaka A; Takeuchi K
Inflammopharmacology; 2005; 13(1-3):209-16. PubMed ID: 16259740
[TBL] [Abstract][Full Text] [Related]
7. Gastroprotective action of glucocorticoid hormones in rats with desensitization of capsaicin-sensitive sensory neurons.
Bobryshev P; Bagaeva T; Filaretova L
Inflammopharmacology; 2005; 13(1-3):217-28. PubMed ID: 16259741
[TBL] [Abstract][Full Text] [Related]
8. [Compensatory gastroprotective action of glucocorticoid hormones in the rats with ablation of capsaicin-sensitive neurons].
Bobryshev PIu; Podvigina TT; Bagaeva TR; Filaretova LP
Ross Fiziol Zh Im I M Sechenova; 2006 Aug; 92(8):1006-15. PubMed ID: 17217252
[TBL] [Abstract][Full Text] [Related]
9. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
[TBL] [Abstract][Full Text] [Related]
10. Gastric mucosal protection against ulcerogenic factors in the rat mediated by capsaicin-sensitive afferent neurons.
Holzer P; Sametz W
Gastroenterology; 1986 Oct; 91(4):975-81. PubMed ID: 3527854
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
Rainsford KD; Stetsko PI; Sirko SP; Debski S
J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of lafutidine against indomethacin-induced intestinal ulceration in rats: relation to capsaicin-sensitive sensory neurons.
Kato S; Tanaka A; Kunikata T; Umeda M; Takeuchi K
Digestion; 2000; 61(1):39-46. PubMed ID: 10671773
[TBL] [Abstract][Full Text] [Related]
13. Atropine-induced gastrointestinal cytoprotection dependences to the intact of vagal nerve against indomethacin-induced gastrointestinal mucosal and microvascular damage in rats.
Karádi O; Nagy Z; Bódis B; Mózsik G
J Physiol Paris; 2001; 95(1-6):29-33. PubMed ID: 11595415
[TBL] [Abstract][Full Text] [Related]
14. Gastric hyperemic response induced by acid back-diffusion in rat stomachs following barrier disruption -- relation to vanilloid type-1 receptors.
Tashima K; Nakashima M; Kagawa S; Kato S; Takeuchi K
Med Sci Monit; 2002 May; 8(5):BR157-63. PubMed ID: 12011761
[TBL] [Abstract][Full Text] [Related]
15. Contribution to safe anti-inflammatory therapy with indomethacin.
Bauerová K; Nosál'ová V; Mihalová D; Navarová J
Cent Eur J Public Health; 2004 Mar; 12 Suppl():S8-10. PubMed ID: 15141962
[TBL] [Abstract][Full Text] [Related]
16. Effect of (S)-4-(1-(5-chloro-2-(4-fluorophenyoxy)benzamido)ethyl) benzoic acid (CJ-42794), a selective antagonist of prostaglandin E receptor subtype 4, on ulcerogenic and healing responses in rat gastrointestinal mucosa.
Takeuchi K; Tanaka A; Kato S; Aihara E; Amagase K
J Pharmacol Exp Ther; 2007 Sep; 322(3):903-12. PubMed ID: 17578900
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of indomethacin ester prodrugs: gastrointestinal and hepatic toxicity and the hydrolytic capacity of various tissues in rats.
Ogiso T; Iwaki M; Tanino T; Nagai T; Ueda Y; Muraoka O; Tanabe G
Biol Pharm Bull; 1996 Sep; 19(9):1178-83. PubMed ID: 8889037
[TBL] [Abstract][Full Text] [Related]
18. Gastric mucosal cellular changes induced by indomethacin (NSAID) in male albino rats.
Sagar V; Ahamed RN
Indian J Exp Biol; 1999 Apr; 37(4):365-9. PubMed ID: 10641173
[TBL] [Abstract][Full Text] [Related]
19. Intestinal protection by lafutidine, a histamine H(2)-receptor antagonist, against indomethacin-induced damage in rats--role of endogenous nitric oxide.
Tanaka A; Mizoguchi H; Hase S; Miyazawa T; Takeuchi K
Med Sci Monit; 2001; 7(5):869-77. PubMed ID: 11535926
[TBL] [Abstract][Full Text] [Related]
20. Role of endogenous prostacyclin in gastric ulcerogenic and healing responses--a study using IP-receptor knockout mice.
Takeuchi K; Kato S; Ogawa Y; Kanatsu K; Umeda M
J Physiol Paris; 2001; 95(1-6):75-80. PubMed ID: 11595421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
